Literature DB >> 14572929

Patient activism and the struggle for diagnosis: Gulf War illnesses and other medically unexplained physical symptoms in the US.

Stephen Zavestoski1, Phil Brown, Sabrina McCormick, Brian Mayer, Maryhelen D'Ottavi, Jaime C Lucove.   

Abstract

We examine Gulf War illnesses--which include the fatigue, joint pain, dermatitis, headaches, memory loss, blurred vision, diarrhea, and other symptoms reported by Gulf War veterans--in relation to other medically unexplained physical symptoms such as multiple chemical sensitivity, chronic fatigue syndrome, and fibromyalgia. Our intent is to examine the diagnosis negotiations involved in these mysterious diseases, by showing the different forms of legitimacy involved in such interactions. Factors involved in diagnostic legitimacy are: diagnostic legitimacy in the medical community, lay acceptance of the diagnosis, uncertainty in looking for causes, and social mobilization. We conclude by noting that research may not be able to find any cause for these diseases/conditions; hence, it may be necessary to embrace medical uncertainty, and also to accept patient experience in order to facilitate diagnosis, treatment, and recovery process. Such a change can alter patients' expectations and taken-for-granted assumptions about medicine, and perhaps in turn reduce the frequency with which dissatisfied individuals form illness groups that mobilize to challenge what they see as an unresponsive medical system.

Entities:  

Mesh:

Year:  2004        PMID: 14572929     DOI: 10.1016/s0277-9536(03)00157-6

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  10 in total

1.  Reflections on Gulf War illness.

Authors:  Simon Wessely; Lawrence Freedman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-04-29       Impact factor: 6.237

2.  Social networks of experientially similar others: formation, activation, and consequences of network ties on the health care experience.

Authors:  Elizabeth A Gage
Journal:  Soc Sci Med       Date:  2012-09-12       Impact factor: 4.634

3.  "Not all my fault": genetics, stigma, and personal responsibility for women with eating disorders.

Authors:  Michele M Easter
Journal:  Soc Sci Med       Date:  2012-07-04       Impact factor: 4.634

4.  Sensory Perception Quotient Reveals Visual, Scent and Touch Sensory Hypersensitivity in People With Fibromyalgia Syndrome.

Authors:  Emma R Dorris; James Maccarthy; Ken Simpson; Geraldine M McCarthy
Journal:  Front Pain Res (Lausanne)       Date:  2022-07-05

5.  Introducing the System for Observing Medical Alliances (SOMA): A Tool for Studying Concordance in Patient-Physician Relationships.

Authors:  Myrna L Friedlander; Kelsey Kangos; Kieran Maestro; Hannah Muetzelfeld; Scott T Wright; Nicole Da Silva; Justin Kimber; Drew A Helmer; Lisa M McAndrew
Journal:  Couns Psychol       Date:  2019-12-16

6.  Use of electronic personal health record systems to encourage HIV screening: an exploratory study of patient and provider perspectives.

Authors:  D Keith McInnes; Jeffrey L Solomon; Barbara G Bokhour; Steven M Asch; David Ross; Kim M Nazi; Allen L Gifford
Journal:  BMC Res Notes       Date:  2011-08-15

7.  Personalized medicine: evidence of normativity in its quantitative definition of health.

Authors:  Henrik Vogt; Bjørn Hofmann; Linn Getz
Journal:  Theor Med Bioeth       Date:  2016-10

8.  Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias.

Authors:  Frederick Wolfe; Brian Walitt; Serge Perrot; Johannes J Rasker; Winfried Häuser
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

9.  Geographies of uncertainty.

Authors:  Nari Senanayake; Brian King
Journal:  Geoforum       Date:  2020-08-14

10.  Under-recognition of medically unexplained symptom conditions among US Veterans with Gulf War Illness.

Authors:  Naomi S Kane; Nicole Anastasides; David R Litke; Drew A Helmer; Stephen C Hunt; Karen S Quigley; Wilfred R Pigeon; Lisa M McAndrew
Journal:  PLoS One       Date:  2021-12-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.